HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The formulation of a pressurized metered dose inhaler containing theophylline for inhalation.

AbstractBACKGROUND:
Theophylline (TP) is a bronchodilator used orally to treat chronic obstructive pulmonary disease (COPD) that has been associated with multiple side effects, tempering its present use. This study aims to improve COPD treatment by creating a low-dose pressurized metered dose inhaler (pMDI) inhalable formulation of TP.
METHODS:
Aerosol performance was assessed using Andersen Cascade Impaction (ACI). Solubility of TP in HFA 134/ethanol mixture was measured and morphology of the particles analyzed with a scanning electron microscope (SEM). Calu-3 cell viability, epithelial cell transport and inflammatory-response assays were conducted to study the impact of the formulation on lung epithelial cells.
RESULTS:
The mass deposition profile of the formulation showed an emitted dose of 250.04±14.48μg per 5 actuations, achieving the designed nominal dose (50μg/dose). SEM showed that the emitted particles were hollow with spherical morphology. Approximately 98% of TP was transported across Calu-3 epithelial cells and the concentration of interleukin-8 secreted from Calu-3 cells following stimulation with tissue necrosis factor-α (TNF-α) resulted in significantly lower level of interleukin-8 released from the cells pre-treated with TP (1.92±0.77ng·ml(-1) TP treated vs. 8.83±2.05ng·ml(-1) TNF-α stimulated, respectively).
CONCLUSIONS:
The solution pMDI formulation of TP developed in present study was shown to be suitable for inhalation and demonstrated anti-inflammatory effects at low doses in Calu-3 cell model.
AuthorsBing Zhu, Mehra Haghi, Mary Goud, Paul M Young, Daniela Traini
JournalEuropean journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences (Eur J Pharm Sci) Vol. 76 Pg. 68-72 (Aug 30 2015) ISSN: 1879-0720 [Electronic] Netherlands
PMID25956075 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2015 Elsevier B.V. All rights reserved.
Chemical References
  • Aerosol Propellants
  • Aerosols
  • Anti-Inflammatory Agents
  • Bronchodilator Agents
  • CXCL8 protein, human
  • Hydrocarbons, Fluorinated
  • Inflammation Mediators
  • Interleukin-8
  • Tumor Necrosis Factor-alpha
  • Ethanol
  • Theophylline
  • apaflurane
Topics
  • Administration, Inhalation
  • Aerosol Propellants (chemistry)
  • Aerosols
  • Anti-Inflammatory Agents (administration & dosage, chemistry)
  • Bronchodilator Agents (administration & dosage, chemistry)
  • Cell Line
  • Chemistry, Pharmaceutical
  • Drug Delivery Systems (instrumentation)
  • Epithelial Cells (drug effects, metabolism)
  • Equipment Design
  • Ethanol (chemistry)
  • Humans
  • Hydrocarbons, Fluorinated (chemistry)
  • Inflammation Mediators (metabolism)
  • Interleukin-8 (metabolism)
  • Metered Dose Inhalers
  • Microscopy, Electron, Scanning
  • Particle Size
  • Pressure
  • Pulmonary Disease, Chronic Obstructive (drug therapy, physiopathology)
  • Respiratory Mucosa (drug effects, metabolism)
  • Solubility
  • Technology, Pharmaceutical (methods)
  • Theophylline (administration & dosage, chemistry)
  • Tumor Necrosis Factor-alpha (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: